C. Hiemke, P. Baumann, N. Bergemann, A. Conca, O. Dietmaier, K. Egberts, Miriam Fric, M. Gerlach, C. Greiner, G. Gründer, E. Haen, U. Havemann-Reinecke, E. J. Sirot, H. Kirchherr, G. Laux, U. Lutz, Thomas A. Messer, Matthias J. Müller, B. Pfuhlmann, B. Rambeck, P. Riederer, B. Schoppek, J. Stingl, M. Uhr, S. Ulrich, R. Waschgler, G. Zernig
2011.9.1PHARMACOPSYCHIATRY
tlooto Summary
Following guidelines for TDM in psychiatry will help to improve the outcomes of psychopharmacotherapy of many patients especially in case of pharmacokinetic problems, and one should never forget that TDM is an interdisciplinary task that sometimes requires the respectful discussion of apparently discrepant data.
Abstract
Abstract is not available.
Citation format
HIEMKE, C., et al. AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: Update 2011. PHARMACOPSYCHIATRY, 2011, 44: 195–235.